Hain Celestials: Still Not A Buy

Herbal tea can't fix what ails Hain Celestials ( HAIN ). Shares of the health food giant are sinking fast, falling more than 13% this morning after the health food company disclosed in a regulatory filing Friday evening that its accounting practices are under investigation by the SEC. UBS analyst Steven Strycula rates the stock a sell with a $33 target price, and warns that under the right circumstances, the shares could fall to $27.